Search research articles
Contact Us
Filters
Showing results (131-140 of 229) with videos related to
Page
of 23
Sort By:
Journal of the American Society of Nephrology : JASN
|
March 29, 2018
An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy
Yi Yang, Harriet Denton, Owen R Davies, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 6, 2026
Single-cell level characterization of B cell depletion and repopulation following rituximab in systemic lupus erythematosus
Haerin Jang, Norzawani Buang, Catherine Sutherland, et al.
Cell Death & Disease
|
September 10, 2020
Autoantibody-dependent amplification of inflammation in SLE
Hantao Lou, Beata Wojciak-Stothard, Marieta M Ruseva, et al.
BMC Family Practice
|
April 30, 2003
Identification of adults with symptoms suggestive of obstructive airways disease: validation of a postal respiratory questionnaire
Timothy L Frank, Peter I Frank, Jennifer A Cropper, et al.
Kidney International
|
May 7, 2015
IgM exacerbates glomerular disease progression in complement-induced glomerulopathy
Sarah E Panzer, Jennifer Laskowski, Brandon Renner, et al.
Journal of the American Society of Nephrology : JASN
|
June 7, 2015
Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy
Marieta M Ruseva, Tao Peng, Melissa A Lasaro, et al.
Kidney International
|
July 30, 2015
An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy
Eva-Maria Nichols, Thomas D Barbour, Isabel Y Pappworth, et al.
Clinical Kidney Journal
|
October 30, 2020
Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression
Maria Prendecki, Candice Clarke, Nicholas Medjeral-Thomas, et al.
Nature Communications
|
April 1, 2021
Type I interferons affect the metabolic fitness of CD8<sup>+</sup> T cells from patients with systemic lupus erythematosus
Norzawani Buang, Lunnathaya Tapeng, Victor Gray, et al.
Kidney International Reports
|
January 15, 2025
Efficacy and Safety of Pegcetacoplan in Kidney Transplant Recipients With Recurrent Complement 3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis
Andrew S Bomback, Erica Daina, Giuseppe Remuzzi, et al.
Page
of 23
Search research articles
Search
Showing results (131-140 of 229) with videos related to
Sort By:
Page
of 23
Journal of the American Society of Nephrology : JASN
|
March 29, 2018
An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy
Yi Yang, Harriet Denton, Owen R Davies, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 6, 2026
Single-cell level characterization of B cell depletion and repopulation following rituximab in systemic lupus erythematosus
Haerin Jang, Norzawani Buang, Catherine Sutherland, et al.
Cell Death & Disease
|
September 10, 2020
Autoantibody-dependent amplification of inflammation in SLE
Hantao Lou, Beata Wojciak-Stothard, Marieta M Ruseva, et al.
BMC Family Practice
|
April 30, 2003
Identification of adults with symptoms suggestive of obstructive airways disease: validation of a postal respiratory questionnaire
Timothy L Frank, Peter I Frank, Jennifer A Cropper, et al.
Kidney International
|
May 7, 2015
IgM exacerbates glomerular disease progression in complement-induced glomerulopathy
Sarah E Panzer, Jennifer Laskowski, Brandon Renner, et al.
Journal of the American Society of Nephrology : JASN
|
June 7, 2015
Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy
Marieta M Ruseva, Tao Peng, Melissa A Lasaro, et al.
Kidney International
|
July 30, 2015
An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy
Eva-Maria Nichols, Thomas D Barbour, Isabel Y Pappworth, et al.
Clinical Kidney Journal
|
October 30, 2020
Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression
Maria Prendecki, Candice Clarke, Nicholas Medjeral-Thomas, et al.
Nature Communications
|
April 1, 2021
Type I interferons affect the metabolic fitness of CD8<sup>+</sup> T cells from patients with systemic lupus erythematosus
Norzawani Buang, Lunnathaya Tapeng, Victor Gray, et al.
Kidney International Reports
|
January 15, 2025
Efficacy and Safety of Pegcetacoplan in Kidney Transplant Recipients With Recurrent Complement 3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis
Andrew S Bomback, Erica Daina, Giuseppe Remuzzi, et al.
Page
of 23